Cat. No. 4773
Chemical Name: α-[(2-(3-Chlorophenyl)hydrazinyliden
Biological ActivityEPAC inhibitor. Inhibits EPAC-mediated insulin releases from pancreatic β cells. Selective for EPAC over PKA. Decreases migration and invasion of AsPc-1 and PANC-1 pancreatic cancer cells in vitro.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Almahariq et al (2013) A novel EPAC-specific inhibitor suppresses pancreatic cancer cell migration and invasion. Mol.Pharmacol. 83 122. PMID: 23066090.
If you know of a relevant reference for ESI 09 please let us know.
Citations are publications that use Tocris products. Selected citations for ESI 09 include:
Wang et al (2015) A pivotal role of FOS-mediated BECN1/Beclin 1 upregulation in dopamine D2 and D3 receptor agonist-induced autophagy activation. EMBO Mol Med 11 2057. PMID: 26649942.
Do you know of a great paper that uses ESI 09 from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: ESI 09, supplier, ESI09, EPAC, exchange, proteins, inhibitors, inhibits, GTPases, Tocris Bioscience, GTPase Inhibitor products